Shares of ARM Holdings PLC Sponsored ADR (NASDAQ:ARM – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twenty-seven brokerages that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and twenty have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $208.7917.
ARM has been the subject of a number of research reports. Jefferies Financial Group set a $290.00 price target on shares of ARM in a research note on Thursday. Weiss Ratings reissued a “hold (c)” rating on shares of ARM in a research note on Monday, April 20th. Mizuho boosted their price target on shares of ARM from $230.00 to $255.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 6th. KeyCorp reissued an “overweight” rating on shares of ARM in a research note on Thursday, February 5th. Finally, Barclays boosted their price target on shares of ARM from $200.00 to $250.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th.
View Our Latest Stock Report on ARM
ARM Trading Up 2.8%
ARM (NASDAQ:ARM – Get Free Report) last posted its earnings results on Wednesday, April 1st. The company reported $0.60 earnings per share for the quarter. ARM had a net margin of 18.37% and a return on equity of 12.43%. The business had revenue of $1.49 billion for the quarter. Research analysts forecast that ARM will post 1.12 earnings per share for the current year.
Trending Headlines about ARM
Here are the key news stories impacting ARM this week:
- Positive Sentiment: Analysts said Nvidia’s bullish comments on Arm-based Vera CPUs support ARM’s growth narrative, with Jefferies reiterating a Buy rating and a $290 price target. Nvidia CPU comments read positively for this chip stock: analyst
- Positive Sentiment: Bernstein initiated coverage with an Outperform rating and a $300 target, highlighting Arm’s potential as AI and custom chip demand expands. Is Arm Holdings (ARM) the Best European Growth Stock to Buy?
- Positive Sentiment: Market commentary continues to frame ARM as a momentum name tied to the AI and CPU renaissance, with investors bidding the shares to fresh highs on expectations for strong profit growth. Arm Holdings (ARM) Hits All-Time High as Profits Seen Rocketing 5x
- Neutral Sentiment: Several insider sales were disclosed this week, including transactions by Charlotte Claire Eaton, CFO Jason Child, William Abbey, and Spencer Collins; most were pre-arranged or routine, but they can still raise valuation caution. SEC filing for insider sales
- Neutral Sentiment: Some recent market commentary says ARM remains a high-momentum stock and a proxy for the AI buildout, which supports the rally but also suggests expectations are elevated. Why Arm Holdings Stock Surged to an All-Time High Today
Insider Buying and Selling
In other news, insider Charlotte Claire Eaton sold 4,000 shares of the company’s stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $282.77, for a total value of $1,131,080.00. Following the completion of the sale, the insider owned 7,805 shares of the company’s stock, valued at approximately $2,207,019.85. This represents a 33.88% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Jason Child sold 31,920 shares of the company’s stock in a transaction on Wednesday, May 20th. The shares were sold at an average price of $226.54, for a total transaction of $7,231,156.80. Following the completion of the sale, the chief financial officer directly owned 174,232 shares of the company’s stock, valued at $39,470,517.28. This trade represents a 15.48% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 276,966 shares of company stock worth $56,798,645 in the last ninety days.
Institutional Investors Weigh In On ARM
A number of institutional investors have recently made changes to their positions in the business. Capital Research Global Investors purchased a new stake in ARM during the 3rd quarter valued at $243,098,000. Northwestern Mutual Wealth Management Co. boosted its position in ARM by 2,623.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 1,671,787 shares of the company’s stock valued at $182,743,000 after buying an additional 1,610,403 shares during the period. Hyperion Asset Management Ltd purchased a new stake in ARM during the 3rd quarter valued at $202,980,000. Employees Provident Fund Board purchased a new stake in ARM during the 4th quarter valued at $120,241,000. Finally, Arrowstreet Capital Limited Partnership boosted its position in ARM by 1,203.5% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 945,152 shares of the company’s stock valued at $142,983,000 after buying an additional 872,644 shares during the period. Hedge funds and other institutional investors own 7.53% of the company’s stock.
ARM Company Profile
Arm Limited (NASDAQ: ARM) is a global semiconductor IP company best known for designing energy-efficient processor architectures and related technologies that underpin a wide range of computing devices. Founded in 1990 as a joint venture between Acorn Computers, Apple and VLSI Technology and headquartered in Cambridge, England, Arm develops the ARM instruction set architectures and core processor designs that chipmakers license and integrate into custom system-on-chip (SoC) products. The company operates a licensing and royalty business model rather than manufacturing chips itself.
Arm’s product portfolio includes CPU core families (such as Cortex and Neoverse lines), GPU and multimedia IP (Mali), neural processing units (Ethos) and a suite of system and physical IP blocks.
Further Reading
- Five stocks we like better than ARM
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
- MarketBeat Week in Review – 05/18 – 05/22
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
Receive News & Ratings for ARM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARM and related companies with MarketBeat.com's FREE daily email newsletter.
